2,454 followers
Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial. #lymphoma #lymsm https://t.co/LYUctQyRfp
Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial. #lymphoma #lymsm https://t.co/LYUctQyRfp
New article: Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial. https://t.co/nlqvEtlfIa #TCL #lymsm #hematology https://t.co/X2p